Directory
>
Victor Perlroth
Victor Perlroth
Chairman and CEO | Kodiak Sciences
Palo Alto, California, United States
Victor Perlroth
Summary
Victor Perlroth is the Chairman and CEO of Kodiak Sciences Inc., a pioneering company in the biopharmaceutical sector, specializing in innovative therapies for serious eye diseases. With a robust background in pharmaceuticals and biotechnology, he has held various leadership roles, including being a Venture Partner at MPM Capital and a member of GlaxoSmithKline's Science and Strategy Board. Victor co-founded Avidia, a biotechnology firm acquired by Amgen, demonstrating his entrepreneurial spirit and deep understanding of protein therapeutics. His educational credentials include an M.D. from Stanford University and an M.B.A. from Stanford's Graduate School of Business, alongside a degree in Molecular Biology from Princeton. His diverse experience spans startups to established corporations, reflecting a strong adaptability in navigating different organizational landscapes. With a keen interest in advancing life sciences, he is committed to driving innovation in healthcare.
Victor Perlroth
Work Experience
Chairman and CEO at
Kodiak Sciences
July 2009 - Present
Member, Science and Strategy Board, Immunoinflammation Therapy Area Unit (iiTAU) at
Glaxosmithkline
January 2009 - January 2015
Venture Partner at
MPM BioImpact
January 2007 - June 2009
Co-founder and General Manager at
AVIDIA Consulting
October 2002 - January 2007
Cofounder of Avidia (acquired by Amgen) at
Amgen, Inc.
January 2003 - January 2006
Entrepreneur in Residence at
Maxygen
January 2002 - January 2003
Chief Operating Officer at
Guzik Technical Enterprises
January 2001 - January 2002
Victor Perlroth
Education
Stanford Graduate School of Business, M.B.A.
January 1999 - January 2001
Stanford University School of Medicine, M.D.
January 1996 - January 2000
Princeton University, A.B.
January 1990 - January 1995
Frequently Asked Questions about Victor Perlroth
What is Victor Perlroth email address?
Victor Perlroth's primary email address is *********@kodiak.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Victor Perlroth work for?
Victor Perlroth is a Chairman and CEO at Kodiak Sciences, a company specializing in Commercial physical research.
Where Victor Perlroth graduated from?
Victor Perlroth holds a degree in from Stanford Graduate School of Business.
How can I directly contact Victor Perlroth?
To contact Victor Perlroth directly, you can use the email address *********@kodiak.com. Complete contact information is available upon registration with Muraena.
Who is Victor Perlroth?
Victor Perlroth is the Chairman and CEO of Kodiak Sciences Inc., a pioneering company in the biopharmaceutical sector, specializing in innovative therapies for serious eye diseases. With a robust background in pharmaceuticals and biotechnology, he has held various leadership roles, including being a Venture Partner at MPM Capital and a member of GlaxoSmithKline's Science and Strategy Board. Victor co-founded Avidia, a biotechnology firm acquired by Amgen, demonstrating his entrepreneurial spirit and deep understanding of protein therapeutics. His educational credentials include an M.D. from Stanford University and an M.B.A. from Stanford's Graduate School of Business, alongside a degree in Molecular Biology from Princeton. His diverse experience spans startups to established corporations, reflecting a strong adaptability in navigating different organizational landscapes. With a keen interest in advancing life sciences, he is committed to driving innovation in healthcare.
Victor`s contact details
*********@kodiak.com
******@perlroth.com
Colleagues
Board Of Directors
Senior Vice President, Chemical Development & Manufacturing
Executive Director Clinical Sciences
Vice President of Biometrics and Clinical Data Science
Vice President, Biologics Development and Manufacturing
Chief Medical Officer
Executive Vice President, Chief Financial Officer